Prediction of progression of glaucomatous optic neuropathy in patients after complex neuroprotection of retinal ganglion cells

Abstract

Glaucoma is a progressive chronic eye disease with gradual loss of visual function and remains the leading cause of blindness in the world. The aim of the work was to study the effectiveness of complex neuroprotection using laser stimulation of the retina/optic disc and the recommended vitamin-antioxidant complex of the AREDS2 formula, enhanced with ω-3 polyunsaturated fatty acids and resveratrol 60 mg in patients with primary open-angle glaucoma. Increase conductivity in the nerve fibers of the optic nerve, improve visual acuity, increase the light sensitivity of the visual analyzer; improve volumetric intraocular blood circulation and reduce vascular spasm. Improve the morphometric parameters of the visual analyzer due to the tendency to thicken the RNFL layer and the GCL+IPL complex. Stabilize the glaucomatous process for 6 months.